| 标题 |
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:Sheryl M. Gough; John J. Flanagan; Jessica Teh; Monica Andreoli; Emma Rousseau; et al 出版日期:2024-05-31 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)